Rosacea Treatment Market Dynamics, Opportunities, Drivers, Restraints, Future Trends And Growth Outl

By Author: DBMR
Total Articles: 306
Comment this article

Market Analysis: Global Rosacea Treatment Market
Rosacea treatment market is rising gradually with a steady CAGR of 3.8% in the forecast period of 2019-2026. High prevalence of rosacea, growing awareness about its therapeutic and increasing research and development for novel therapies for treatment are some major factors that drive the market growth.
Market Definition: Global Rosacea Treatment Market
Rosacea is a chronic, inflammatory skin condition that is characterized by redness on skin. The symptoms are most common at cheeks, nose and forehead. The blush of redness can also spread to other parts such as ears, chest and back. It could be triggered due to heat, caffeine or stress.
Rosacea is often underdiagnosed or misdiagnosed as acne, making it hard to find out the exact prevalence rate of the disease. This disease is more prevalent in fair skin people. An estimated of 14 million people in the America suffers from rosacea.
Get More Insights About Global Rosacea Treatment Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-rosacea-treatment-market
...
... Market Drivers
• Increasing government initiatives and investments in the treatment market will contribute in the market growth
• Increasing research and development of advanced formulations for treatment of different types of rosacea and acne are expected to drive the market growth
• Increasing prevalence rate of the disease acts as driver of market growth
• Growing awareness about rosacea and its available therapeutics will increase the market size
Market Restraints
• Multiple patent expiries bring a significant number of generic products that hampers the growth of market
• Off-label usage of medicines for rosacea can also restrict the market growth
• Rosacea is often underdiagnosed or misdiagnosed as acne hampers the market growth
Know more about this report https://www.databridgemarketresearch.com/reports/global-rosacea-treatment-market
Segmentation: Global Rosacea Treatment Market
By Type
• Erythematotelangiectatic Rosacea
• Papulopustular Rosacea
• Ocular Rosacea
• Phymatous Rosacea
By Drugs Class
• Antibiotics
• Immunosuppressants
• Corticosteroids
• Others
By Drugs
• Rhofade
• Mirvaso
• Oracea
• Others
By Route of Administration
• Oral
• Topical
• Others
By End Users
• Hospitals
• Homecare
• Specialty Clinics
• Others
By Distribution Channels
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• Others
By Geography
• North America
o U.S.
o Canada
o Mexico
• South America
o Brazil
o Rest of South America
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Turkey
o Belgium
o Netherlands
o Switzerland
o Rest of Europe
• Asia-Pacific
o Japan
o China
o South Korea
o India
o Australia
o Singapore
o Thailand
o Malaysia
o Indonesia
o Philippines
o Rest of Asia Pacific
• Middle East & Africa
o South Africa
o Rest of Middle East & Africa
Key Developments in the Market:
• In August 2019, Foamix Pharmaceuticals Ltd. submitted a New Drug Application (NDA) to the U. S. FDA for FMX103 (minocycline) for the treatment of moderate-to-severe papulopustular rosacea. This application is based on the positive topline results of phase III clinical trials of FMX103. This drug candidate will be an efficacious treatment with a well-tolerated profile and will be present in a convenient topical foam formulation
• In January 2017, ALLERGAN received the U. S. FDA approval for RHOFADE topical cream used for treatment of adults with persistent facial erythema associated with rosacea. The approval was based on two clinical trials which met the primary efficacy endpoint. This approval will provide ALLERGAN all the right for production and commercialization of this novel formulation.
Get Access Report @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/global-rosacea-treatment-market
Competitive Analysis:
Global rosacea treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of rosacea treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Key Market Players:
Few of the major competitors currently working in the global rosacea treatment market are Foamix Pharmaceuticals Ltd., ALLERGAN, Bausch Health, Sol-Gel Technologies Ltd., Bayer AG, Nestlé, PRUGEN, Merck & Co., Inc., AbbVie Inc., Unilever, Croda International Plc, Colorescience, Inc., Perrigo Company plc, Aclaris Therapeutics, Inc., Lupin Pharmaceuticals, Inc., Supernus Pharmaceuticals, Inc, Dr. Reddy’s Laboratories Ltd., Mylan N.V. among others.
Primary Respondents
Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Request for Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-rosacea-treatment-market
Browse Trending Related Reports @
• Pyelonephritis Treatment Market
• Smith-Lemli-Opitz Syndrome Market
• Urothelial Cancer Drugs Market
• Vitiligo Treatment Market
• Dry Eye Syndrome Market
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com